Fresenius Medical Care AG cash flow statement FMS
In fiscal 2013, which ended Dec 31, 2013, Fresenius Medical Care AG generated $2.0 billion of cash from operations, down 0.2% from the year before. It spent $747.9 million on capital expenditures. That left free cash flow of $1.3 billion. The company returned $296.1 million in dividends to shareholders.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2013
Dec 31, 2013
|
FY 2012
Dec 31, 2012
|
FY 2011
Dec 31, 2011
|
FY 2010
Dec 31, 2010
|
FY 2009
Dec 31, 2009
|
|---|---|---|---|---|---|
| Operating | |||||
| Depreciation and amortization |
648
+7.5%
|
603
+8.2%
|
557
+10.7%
|
503
+10.1%
|
457
|
| Stock-based compensation |
—
|
2
-11.4%
|
3
+0.0%
|
3
|
—
|
| Operating cash flow |
2,035
-0.2%
|
2,039
+41.0%
|
1,446
+5.7%
|
1,368
+2.2%
|
1,339
|
| Investing | |||||
| Capital expenditures |
748
+10.8%
|
675
+13.0%
|
598
+14.2%
|
524
-8.7%
|
574
|
| Investing cash flow |
-1,206
+47.2%
|
-2,281
+2.8%
|
-2,346
-108.5%
|
-1,125
-61.2%
|
-698
|
| Financing | |||||
| Debt repaid |
617
-82.8%
|
3,589
+274.9%
|
957
-10.8%
|
1,073
+89.5%
|
566
|
| Short-term debt issued |
382
+118.8%
|
174
-8.2%
|
190
-32.4%
|
281
+162.2%
|
107
|
| Short-term debt repaid |
398
+143.9%
|
163
-34.5%
|
249
-3.8%
|
259
+52.8%
|
169
|
| Dividends paid |
296
+9.0%
|
272
-3.2%
|
281
+21.0%
|
232
+0.0%
|
232
|
| Financing cash flow |
-808
-272.5%
|
468
-41.0%
|
793
+5489.4%
|
-15
+97.4%
|
-558
|
| Change in cash | |||||
| Effect of exchange rate |
-26
-677.1%
|
5
-88.7%
|
41
+703.2%
|
-7
-138.5%
|
-3
|
| Free cash flow |
1,287
-5.6%
|
1,364
+60.7%
|
849
+0.5%
|
844
+10.4%
|
765
|
| Per share | |||||
| Free cash flow per share |
4.25
-5.5%
|
4.50
+59.6%
|
2.82
-0.4%
|
2.83
|
—
|
| Shareholder returns | |||||
| Returned to shareholders |
296
|
272
|
281
|
232
|
232
|
| Share of free cash flow |
23.01%
|
19.93%
|
33.07%
|
27.47%
|
30.32%
|
| Ratios | |||||
| Free cash flow margin |
25.89%
|
—
|
—
|
—
|
—
|
| Capital expenditures to revenue |
15.05%
|
—
|
—
|
—
|
—
|
| Cash conversion |
1.83x
|
1.72x
|
1.35x
|
1.40x
|
1.50x
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- FMS (NYSE), FMCQF (OTC)
- Headquarters
- Bad Homburg, Germany
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1333141
- Former names
- Fresenius Medical Care AG & Co. KGaA (until Nov 21, 2023)
Other Services-Misc Health & Allied Services, NEC companies
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
- Marpai, Inc. MRAI
All 15 Services-Misc Health & Allied Services, NEC companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.